Skip to main content

Advertisement

SpringerLink
Log in

Mutant Wilms’ tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD)

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Yang L, Han Y, Suarez Saiz F, Minden MD . A tumor suppressor and oncogene: the WT1 story. Leukemia 2007; 21: 868–876.

    Article  CAS  Google Scholar 

  2. King-Underwood L, Pritchard-Jones K . Wilms′ tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 1998; 91: 2961–2968.

    CAS  Google Scholar 

  3. Summers K, Stevens J, Kakkas I, Smith M, Smith LL, Macdougall F et al. Wilms’ tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia 2007; 21: 550–551.

    Article  CAS  Google Scholar 

  4. Paschka P, Marcucci G, Ruppert AS, Whitman SP, Mrozek K, Maharry K et al. Wilms tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B Study. J Clin Oncol 2008; 26: 4595–4602.

    Article  CAS  Google Scholar 

  5. Virappane P, Gale R, Hills R, Kakkas I, Summers K, Stevens J et al. Mutation of the Wilms tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 2008; 26: 5429–5435.

    Article  CAS  Google Scholar 

  6. Gaidzik VI, Schlenk RF, Moschny S, Becker A, Bullinger L, Corbacioglu A et al. Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG). Blood 2009; 113: 4505–4511.

    Article  CAS  Google Scholar 

  7. Kuzmiak HA, Maquat LE . Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 2006; 12: 306–316.

    Article  CAS  Google Scholar 

  8. Wouters BJ, Jorda MA, Keeshan K, Louwers I, Erpelinck-Verschueren CA, Tielemans D et al. Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood 2007; 110: 3706–3714.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Supported by grants from the Dutch Cancer Society (Koningin Wilhelmina Fonds)

Author information

Authors and Affiliations

  1. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

    S Abbas, C A J Erpelinck-Verschueren, C S Goudswaard, B Löwenberg & P J M Valk

Authors
  1. S Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C A J Erpelinck-Verschueren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C S Goudswaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B Löwenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P J M Valk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P J M Valk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abbas, S., Erpelinck-Verschueren, C., Goudswaard, C. et al. Mutant Wilms’ tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD). Leukemia 24, 660–663 (2010). https://doi.org/10.1038/leu.2009.265

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2009.265

  • Springer Nature Limited

Search

Navigation